glp 1 ocd Is GLP-1 (Glucagon-like peptide-1) a recommended treatment for Obsessive-Compulsive Disorder (OCD)? Long-term Success of GLP-1s Hinges

Diabetes, Obesity and Metabolism , 25 (1), 18-35

Do you have more questions about GLP-1s

Switching Between Them: From Mounjaro to Semaglutide: Take last Mounjaro dose Wait one week Start semaglutide at 0.5-1.0 mg (provider determines dose) Adjust based on response From Semaglutide to Tirzepatide: Take last semaglutide dose Wait one week Start tirzepatide at 2.5-5 mg (provider determines dose) Escalate according to standard protocol Switching is safe and common

Always confirm current pricing and state availability directly with the provider before starting treatment

Brand-name GLP-1 makers, such as Lilly and Novo Nordisk, package the drugs in auto-injector pens that dispense standard doses

BioWorld - Saturday, July 18, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Innovent gets IND for oral GLP-1 agonist To read the full story, subscribe or sign in